Aster Capital Management
NUVB icon

Aster Capital Management’s Nuvation Bio NUVB Stock Holding History

Aster Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1,420
Closed -$8.07K – 1212
2026
Q2 		$8.07K Buy
+1,420
New +$6.94K ﹤0.01% 687
2026
Q1 		– Sell
-1,426
Closed -$12.8K – 1179
2025
Q4 		$12.8K Buy
+1,426
New +$8.83K 0.01% 708

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Aster Capital Management's NUVB Position: Q3 2026 in Review

Aster Capital Management sold out of Nuvation Bio (NUVB) in Q3 2026, closing a stake of 1,420 shares — an estimated $8.07K sold.

Aster Capital Management first reported a position in NUVB in Q4 2025 and held it in 2 quarters. The position peaked at $12.8K in Q4 2025. 147 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • Aster Capital Management reported no remaining Nuvation Bio position as of Q3 2026 after selling out during the quarter.
  • Aster Capital Management sold 1,420 Nuvation Bio shares in Q3 2026, an estimated $8.07K.
  • Aster Capital Management first reported a position in Nuvation Bio in Q4 2025 and held it in 2 quarters.
  • Aster Capital Management's Nuvation Bio position peaked at $12.8K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.